Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma

Gynecologic Oncology

Volumn 83, Issue 3, 2001, Pages 569-574

  Ayhan, Ayşe ^a   Baykal, Cem ^a   Al, Atakan ^a   Ayhan, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

CD44v6; Cervical carcinoma; Prognosis

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM;

EID: 0035205955     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6406     Document Type: Article

References (37)

1. CD44 - A molecule involved in leukocyte adherence and T-cell activation
2. CD44 isoforms impact on lymphocyte activation and differentiation
3. CD44 is the principal cell surface receptor for the hyaluronate
4. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family
5. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin
6. Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
7. CD44 isoforms during differentation and development
8. Significance fo CD44 gene products for cancer diagnosis and disease evaluation
9. Increased susceptibility to primary infection with Listeria monocytogenes in germ-free mica may be due to lack of accumulation of i-selectin+CD44+ T cells in sites of inflammation
10. Alternative splicing in the control of gene expression
11. CD44 variant exon epitopes in primary breast cancer and length of survival
12. Differential expression of CD44 splice variants in intestinal and diffuse type human gastric carcinomas and normal gastric mucosa
13. Colorectal cancer prognosis and expression of exon v6-containing CD++ proteins
14. Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma
15. Splice variants of CD44 in human cervical cancer stage IB to IIB
16. CD44 splice variants: Metastases meet lymphocytes
17. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal epithelium
18. Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis
19. Immunohistochemical detection of CD44 splice variant expression in premalignantant lesions of the cervix and benign cervical epithelium
20. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia
21. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical carcinoma
22. The CD44 adhesion molecule and metastasis
23. Are CD44 variant isoforms involved in human tumour progression?
24. Prevention of tumour metastasis formation by anti-variant CD44
25. Participation in normal immune responses of a metastasis-inducing splice variant of CD44
26. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression
27. CD44 is an independent prognostic factor in early stage cervical cancer
28. CD44v6 expression is an independent prognostic factor in node-negative FIGO stage IB cervical carcinoma
29. CD44 splice variant expression in normal and malignantant uterine cervical epithelium
30. Expression of CD44 in uterine cervical squamous neoplasia: A predictor of microinvasion?
31. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer
32. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression
33. Staging announcement
34. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
35. Prognostic value of CD44 splice variants in human cervical cancer stage III
36. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical cancer
37. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer